Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 47 min ago
Peer-reviewedCC BY-NC-NDLipids in health and disease

Sex-dimorphic phenotypic divergence in metabolically driven thyroid nodules: the interplay of systemic inflammation and adiposity.

10 affiliations
  1. 1Department of Pharmacy, Foshan University Affiliated Third Hospital, Guangdong, China.
  2. 2Department of Clinical Nutrition, Northeast Yunnan Central Hospital, Northeast Yunnan Hospital of Kunming Medical University, Northeast Yunnan Clinical School of Kunming Medical University, Zhaotong, 657000, Yunnan, China.
  3. 3Department of Endocrinology, Foshan University Affiliated Third Hospital, Guangdong, China.
  4. 4Information Technology Department, Northeast Yunnan Central HospitalNortheast Yunnan Hospital of Kunming Medical UniversityNortheast Yunnan Clinical School of Kunming Medical University, Zhaotong, 657000, Yunnan, China.
  5. 5Department of Medical Ultrasonics, Northeast Yunnan Central HospitalNortheast Yunnan Hospital of Kunming Medical UniversityNortheast Yunnan Clinical School of Kunming Medical University, Zhaotong, 657000, Yunnan, China.
  6. 6Nursing Department, Northeast Yunnan Central HospitalNortheast Yunnan Hospital of Kunming Medical UniversityNortheast Yunnan Clinical School of Kunming Medical University, Zhaotong, 657000, Yunnan, China.
  7. 7Department of Clinical Laboratory, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
  8. 8Department of Pulmonary and Critical Care Medicine, Northeast Yunnan Central HospitalNortheast Yunnan Hospital of Kunming Medical UniversityNortheast Yunnan Clinical School of Kunming Medical University, Zhaotong, 657000, Yunnan, China. [email protected].
  9. 9Kunming Medical University, Kunming, 650500, Yunnan, China. [email protected].
  10. 10Hematology Department, Northeast Yunnan Central HospitalNortheast Yunnan Hospital of Kunming Medical UniversityNortheast Yunnan Clinical School of Kunming Medical University, Zhaotong, 657000, Yunnan, China. [email protected].

Abstract

Background

Metabolic dysfunction has been increasingly implicated in thyroid nodule development; however, the sex-specific interplay between systemic glucolipotoxicity, adiposity, inflammation, and thyroid nodule risk remains poorly understood. This study aimed to evaluate the association between the composite cholesterol, high-density lipoprotein, and glucose (CHG) index and thyroid nodules (TNs) and to explore the potential factors underlying sex-specific differences across Thyroid Imaging Reporting and Data System (TI-RADS) risk categories.Methods

This large-scale health check-up cohort included 24,878 participants who underwent routine health examinations in a unique sub-plateau cohort (altitude, ~ 2,000 m). The TNs were identified using high-resolution ultrasonography and classified using the TI-RADS grading system. The CHG index was used to quantify systemic metabolic burden. Guided by directed acyclic graphs (DAGs) for covariate selection, multivariable logistic regression was used to evaluate independent associations, and restricted cubic splines were used to assess nonlinear dose-response relationships. Statistical mediation analysis using red blood cell distribution width (RDW) as the mediator quantified the proportion attributable to systemic inflammation.Results

Multivariable analyses revealed significant sex-dimorphic associations between the CHG index and TN risk. In men, elevated CHG levels were consistently associated with increased risk across nodular grades. Notably, the association with high-risk nodules (TI-RADS 4) was markedly attenuated and no longer statistically significant after adjusting for BMI, suggesting that adiposity may partly account for this association. Mediation analysis indicated that low-grade systemic inflammation (RDW) statistically explained a significant proportion of the metabolic-nodule association in men. In women, higher CHG was inversely associated with early-stage (TI-RADS 2) nodules. This pattern was more apparent among women aged ≥ 50 years, suggesting potential age-related heterogeneity; however, this finding should be interpreted with caution because direct hormonal data were unavailable. Furthermore, the CHG index demonstrated superior risk reclassification utility compared to isolated lipid parameters.Conclusion

The CHG index is associated with thyroid risk stratification in a sex-specific manner. These findings indicate that sex-dependent physiological characteristics may modify the association between metabolic factors and high-risk thyroid morphological patterns. In men, these patterns were more strongly associated with adiposity and inflammation, whereas in older women, these patterns may be related to adaptive morphological changes. These findings may inform sex-specific metabolic management strategies for thyroid care.

Related

  1. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice
    Noriaki Kawanishi, Hiromi Yano, Yuka Yokogawa +1
    PubMedPeer-reviewedLicence not stated456 citedEndocrinology & metabolismEpidemiology & public healthOpenAlex
  2. The interplay of insulin resistance and systemic inflammation on cancer history: a nationally representative cross-sectional study from NHANES
    Xiaorui Wang
    Cardiovascular diabetology. Endocrinology reportsPeer-reviewedCC BY 4.0Full textOncologyPMC
  3. CO067 | ELUCIDATING THE EVIL RELATIONSHIP OF METABOLIC DYSFUNCTION–ASSOCIATED FATTY LIVER DISEASE WITH CARDIOVASCULAR COMORBIDITIES: THE COMPLEX INTERPLAY AMONG HYPERCOAGULABILITY, INFLAMMATION, AND LIVER FIBROSIS
    Elena Campello
    Bleeding, Thrombosis and Vascular BiologyPeer-reviewedCC BY-NCFull textCardiovascular medicineDOAJ
  4. Metabolically Unhealthy Obesity: Novel Subtypes Defined by Integrated Metabolomics and Hematology
    Xuan Huang, Yuhong Liu, Xiaoqian Zhu +3
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy
    Sébastien Frey, Stéphanie Patouraux, Tarek Debs +3
    Surgery for Obesity and Related DiseasesPeer-reviewedLicence not statedFull text30 citedGeneral biologySurgery & anaesthesiaHAL
BibTeX
@article{fan2026sexdimorphic,
  title = {{Sex-dimorphic phenotypic divergence in metabolically driven thyroid nodules: the interplay of systemic inflammation and adiposity.}},
  author = {Huanqiong Fan and Yingyong Yin and Shaopeng Huang and Zhibo Cui and Ling Dao and Daishan Li and Xiaoxiao Qu and Guosong Jiang and Chi-E Qiu},
  journal = {Lipids in health and disease},
  year = {2026},
  month = aug,
  doi = {10.1186/s12944-026-03021-1},
  url = {https://europepmc.org/article/MED/42958337},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Sex-dimorphic phenotypic divergence in metabolically driven thyroid nodules: the interplay of systemic inflammation and adiposity.
AU  - Huanqiong Fan
AU  - Yingyong Yin
AU  - Shaopeng Huang
AU  - Zhibo Cui
AU  - Ling Dao
AU  - Daishan Li
AU  - Xiaoxiao Qu
AU  - Guosong Jiang
AU  - Chi-E Qiu
PY  - 2026
DA  - 2026/08/03
JO  - Lipids in health and disease
DO  - 10.1186/s12944-026-03021-1
UR  - https://europepmc.org/article/MED/42958337
AB  - Background  Metabolic dysfunction has been increasingly implicated in thyroid nodule development; however, the sex-specific interplay between systemic glucolipotoxicity, adiposity, inflammation, and thyroid nodule risk remains poorly understood. This study aimed to evaluate the association between the composite cholesterol, high-density lipoprotein, and glucose (CHG) index and thyroid nodules (TNs) and to explore the potential factors underlying sex-specific differences across Thyroid Imaging Reporting and Data System (TI-RADS) risk categories.Methods  This large-scale health check-up cohort included 24,878 participants who underwent routine health examinations in a unique sub-plateau cohort (altitude, ~ 2,000 m). The TNs were identified using high-resolution ultrasonography and classified using the TI-RADS grading system. The CHG index was used to quantify systemic metabolic burden. Guided by directed acyclic graphs (DAGs) for covariate selection, multivariable logistic regression was used to evaluate independent associations, and restricted cubic splines were used to assess nonlinear dose-response relationships. Statistical mediation analysis using red blood cell distribution width (RDW) as the mediator quantified the proportion attributable to systemic inflammation.Results  Multivariable analyses revealed significant sex-dimorphic associations between the CHG index and TN risk. In men, elevated CHG levels were consistently associated with increased risk across nodular grades. Notably, the association with high-risk nodules (TI-RADS 4) was markedly attenuated and no longer statistically significant after adjusting for BMI, suggesting that adiposity may partly account for this association. Mediation analysis indicated that low-grade systemic inflammation (RDW) statistically explained a significant proportion of the metabolic-nodule association in men. In women, higher CHG was inversely associated with early-stage (TI-RADS 2) nodules. This pattern was more apparent among women aged ≥ 50 years, suggesting potential age-related heterogeneity; however, this finding should be interpreted with caution because direct hormonal data were unavailable. Furthermore, the CHG index demonstrated superior risk reclassification utility compared to isolated lipid parameters.Conclusion  The CHG index is associated with thyroid risk stratification in a sex-specific manner. These findings indicate that sex-dependent physiological characteristics may modify the association between metabolic factors and high-risk thyroid morphological patterns. In men, these patterns were more strongly associated with adiposity and inflammation, whereas in older women, these patterns may be related to adaptive morphological changes. These findings may inform sex-specific metabolic management strategies for thyroid care.
SN  - 1476-511X
ER  -